Ergonomics in the Cardiac Catheterization Laboratory

NCT ID: NCT06506968

Last Updated: 2024-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-13

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to quantify ergonomic risk associated with traditional protective equipment in operators working in the cardiac catheterization laboratory as compared with a mobile protection system. The main questions it aims to answer is:

What is the mean time spent by operators in positions of high ergonomic postural risk during cases?

Participants will wear IMU, EMG, and radiation sensors, as well as complete baseline and discomfort surveys for several catheterization procedures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study subjects will wear the following equipment on their head and back including: four IMU sensors, eight EMG sensors, and one radiation sensor. Before the catheterization procedure, members of the study team will affix the IMUs on the subject and ensure that the devices are properly calibrated using a calibration procedure as per manufacturer protocol: standing upright with arms and fingers pointing downward and the thumb pointing forward, leaning forward hinging at the hips, and a final pose returning to upright standing position. Participants will periodically be asked to return to upright position to avoid IMU drift. Video of the procedure will also be used for IMU data quality assurance. EMG sensors will also be affixed to the subject and calibrated using the MVC function as per manufacturer protocol: the subject will complete exercises to elicit the maximum muscle activation from each muscle an EMG is placed on. Measures will be taken to reduce EMG impedance including cleaning the skin with alcohol wipes prior to application. One radiation sensor will be clipped to the outside of the participant's clothing, and another will be placed near the left shoulder of the patient as the control.

The IMU sensors will measure body posture angles by the fusion of data from the accelerometer, magnetometer, and gyroscope contained within each sensor. The EMG sensors will measure the muscle activity using non-invasive electrodes on the surface of the skin. The radiation dosimeter will capture radiation received by the participant during each case. The acquired data will be stored locally on the device and upon completion of the procedure, will be removed and the data downloaded by investigator team to the study laptop, offline, utilizing the Ultimum software provided by Noraxon and analyzed with Microsoft Excel and STATA statistical analytic software. Neither the study sponsor RAMPART nor the supplier Noraxon will be permitted to access this data. Specific datasheets will be tabulated per subject and aggregated for time spent in procedures utilizing lead vs procedures in which the RAMPART M1128 device was utilized and lead protective equipment was obviated. Objective EPR will be determined and based on the amount of time the individual body segments were exposed to various postures. Body angles will be assessed and stratified into risk categories (defined as minimal, mild, moderate and high risk and will be assigned modified rapid upper limb risk assessment scores of 1.0, 2.0, 3.0 and 4.0, respectively) and based on the measured body angles in accordance with the modified rapid upper limb assessment During each procedure, the percent time spent in a prespecified range of risk categories for each body part will be calculated. Study staff will mark on a datasheet the procedure type and duration for record. Mean reported discomfort scores will also be calculated at the designated body regions of interest and compared between procedures, as well as with and without the RAMPART device, and across procedure type and duration. Given that the study will be conducted with a single IMU and EMG sensor set, we plan to allow for each subject to utilize the sensor system for up to six cases at a time before rotating to the subsequent subject. This methodology will allow for uninterrupted and less fragmented data acquisition per study subject.

Participants will be asked to complete a baseline survey consisting of questions on demographics, history of orthopedic injury, as well as their years of experience/in practice.

The post procedure surveys will consist of body segment musculoskeletal discomfort ratings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ergonomics Orthopedic Injury Wellness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any member of the BWH cardiac catheterization laboratory who participates in procedures including:
* faculty interventional cardiologists and trainees
* general cardiology fellows
* residents
* physician assistants
* nurses
* circulating and monitoring technologists
* Physically able and willing to wear the sensors required for data collection in the study

Exclusion Criteria

* Interventionalists not actively participating in the BWH Cardiac Catheterization Lab
* Not able or willing to wear the necessary sensors
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rampart ic, LLC

UNKNOWN

Sponsor Role collaborator

Brigham and Women's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ajar Kochar

Program Director for Interventional Cardiology Fellowship

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ajar Kochar

Role: PRINCIPAL_INVESTIGATOR

Brigham and Women's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brigham and Women's Hospital

Boston, Massachusetts, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ajar Kochar

Role: CONTACT

857-307-4000

Raghav Gattani

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ajar Kochar, MD, MHS

Role: primary

857-407-4561

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023P000484

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Assessment of Spinal Stability
NCT01060358 COMPLETED